Healthcare SaaS | FDA-Approved | High Recurring Revenue | Large LOI Pipeline

Company Overview

PRIME exits® and American HealthCare Capital are pleased to exclusively represent a U.S.-based AI health tech company that is offering a majority equity stake in a rapidly scaling platform that automates medical imaging workflows. This cloud-native, FDA- and HIPAA-compliant solution is already deployed across hundreds of healthcare sites, supporting thousands of physicians. Its AI engine streamlines reporting in cardiology, radiology, and clinical documentation, reducing turnaround time by up to 90% and boosting revenue for outpatient clinics and specialty centers.

Financial Overview

With a robust pipeline of $200 million in signed LOIs and a forecasted ARR of $8.4 million by the end of 2026 from the current $1.3M ARR. The company is poised for exponential growth. The leadership team seeks a capital or strategic partner to help execute on deployment, marketing expansion, and potential international rollout. The structure includes an earn-out based on milestone achievements.

Opportunity Summary

Asking Price: $70M including an earn out based on achieving the financial milestones

Capital Structure: Clean, no debt

Client Retention: 100% over 4 years

ARR Growth: 80% QoQ since launch

Use of Funds: Fulfillment of LOIs, hiring, tech enhancement, market expansion

Note: *Due to rapid growth the information including the valuation will change- Request a call with the team ASAP if this opportunity is of an interest.